Long-term galantamine treatment improved survival; lowered blood pressure; reduced renal injury markers, including urinary albumin, kidney injury molecule-1, and neutrophil gelatinase-associated lipocalin; and decreased renal fibrosis in female mice with SLE. Here, ALB is linked to systemic lupus erythematosus.